Skip to main content
Livermore
Livermore
ZHEN

BNP Paribas Arbitrage, SA

SEC CIK
0001166588
Latest filing
Aug 13, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
63,977
Value
$666.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RNAC by BNP Paribas Arbitrage, SA, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202663,977$666.6K<0.1%+54,027+543.0%AddedHolders
Q1 20269,950$61.2K<0.1%+7,536+312.2%AddedHolders
Q4 20252,414$17.4K<0.1%+174+7.8%AddedHolders
Q3 20252,240$22.9K<0.1%+862+62.6%AddedHolders
Q2 20251,378$14.3K<0.1%+360+35.4%AddedHolders
Q1 20251,018$13.4K<0.1%−627−38.1%ReducedHolders
Q4 20241,645$29.5K<0.1%−6−0.4%ReducedHolders
Q3 20241,651$26.6K<0.1%+909+122.5%AddedHolders
Q2 2024742$20.0K<0.1%−58,383−98.7%ReducedHolders
Q1 202459,125$38.4K<0.1%+24,822+72.4%AddedHolders
Q4 202334,303$23.6K<0.1%+3,030+9.7%AddedHolders
Q3 202331,273$33.1K<0.1%+950+3.1%AddedHolders
Q2 202330,323$34.0K<0.1%+29,051+2,283.9%AddedHolders
Q1 20231,272$1.77K<0.1%−262−17.1%ReducedHolders
Q4 20221,534$1.73K<0.1%+835+119.5%AddedHolders
Q3 2022699$1.15K<0.1%−34,562−98.0%ReducedHolders
Q2 202235,261$46.2K<0.1%−290,690−89.2%ReducedHolders
Q1 2022325,951$400.9K<0.1%−15,873−4.6%ReducedHolders
Q4 2021341,824$1.11M<0.1%+318,822+1,386.1%AddedHolders
Q3 202123,002$95.7K<0.1%+15,749+217.1%AddedHolders
Q2 20217,253$30.3K<0.1%−10,702−59.6%ReducedHolders
Q1 202117,955$81.2K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.